US Executive Compensation Proxy SEC Filings — August 04, 2026

04-08-2026

Noble Roman's, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Shareholders to be held on September 15, 2026. The Board unanimously recommends the re-election of A. Scott Mobley as Class III director and Paul W. Mobley as Class II director, and the ratification of Stephano Slack as independent auditor for fiscal year 2026. The proxy statement also discloses that as of August 10, 2026, there were 22,707,749 shares outstanding, with executive officers and directors as a group beneficially owning 23.7% of the common stock.

• · The annual meeting will be held on September 15, 2026 at 10:30 a.m. local time in Indianapolis, Indiana.
• · The record date for voting is August 10, 2026.
• · The Board of Directors has a classified structure with three classes of directors serving staggered three-year terms.
• · No quorum was present at the previous year's annual meeting, so no vote was taken; the Class II director continued to serve until this year's meeting.
• · Paul W. Mobley, age 85, is the father of A. Scott Mobley, age 62.
• · Jeffrey Roberts was appointed as a director in 2025.
• · The ratification of Stephano Slack as independent auditor is considered a 'routine' matter, allowing brokers to vote on it without instructions from beneficial owners.

04-08-2026

First Real Estate Investment Trust of New Jersey, Inc. (FREVS) has filed a definitive proxy statement (DEFM14A) to solicit stockholder approval for a Plan of Liquidation and dissolution, including the sale of all assets and the winding-up of the Trust. The filing provides an estimated range of aggregate final distributions to stockholders, but the exact amounts and timing remain uncertain due to factors such as asset sale prices, transaction costs, and potential liabilities. The Board may delay or modify the plan without further stockholder approval, and there are risks that distributions could be delayed or reduced if asset sales underperform or costs exceed estimates.

• · The filing is a definitive proxy statement (DEFM14A) filed on August 4, 2026, for a Special Meeting to approve the Plan of Liquidation.
• · The Trust may be subject to a 100% excise tax on prohibited transactions if property sales are deemed inventory-like or dealer sales.
• · The Board may acquire insurance policies for unknown or contingent claims, with premiums not yet determined.
• · The Trust may provide financing to purchasers of properties, which could delay distributions until installment payments are received.
• · If the Trust loses its REIT status, it would be subject to corporate income tax, reducing funds available for distribution.
• · Stockholders can contact the Trust's proxy solicitor, Georgeson, for questions.

04-08-2026

AAR Corp. filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting, highlighting record financial results with sales of $3.3B, diluted EPS of $4.86, and adjusted diluted EPS of $5.05 (up 29% YoY). However, cash flow from operations declined to $99M from $36.1M in FY2025, and total debt remained high at $900M. The company completed four acquisitions and expanded facilities, but also initiated the wind-down of its Commercial Programs business to improve margins.

• · The annual meeting will be held virtually on September 23, 2026, at 9:00 a.m. Central Time.
• · Stockholders of record as of July 28, 2026, are entitled to vote.
• · Proposals include electing three director nominees, advisory vote on executive compensation, approval of a new stock plan, and ratification of KPMG as auditor.
• · General Duncan J. McNabb is retiring from the Board at the 2026 annual meeting.
• · The company renewed 100% of new parts Distribution contracts in FY2026.
• · AAR expanded its Safety Management System to newly acquired repair facilities and conducted an anonymous safety culture survey with 93% participation.

04-08-2026

AMREP Corporation filed its definitive proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for September 10, 2026. The meeting will include the election of two Class III directors, approval of the new 2026 Equity Compensation Plan, an advisory vote on executive compensation, and ratification of the independent auditor. The Board recommends a 'For' vote on all proposals, and the record date is July 20, 2026, with 5,324,849 shares outstanding.

• · Annual Meeting to be held at Hilton Garden Inn, 3743 West Chester Pike, Newtown Square, Pennsylvania 19073 on September 10, 2026 at 9:00 A.M. Eastern Time.
• · Record date for shareholders is July 20, 2026.
• · Proposal 1: Election of two Class III directors to serve until 2029 annual meeting.
• · Proposal 2: Approval of the AMREP Corporation 2026 Equity Compensation Plan.
• · Proposal 3: Advisory vote on executive compensation.
• · Proposal 4: Ratification of Rosenberg Rich Baker Berman, P.A. as independent auditor for fiscal year 2027.
• · Board recommends 'For' votes on all proposals.
• · Proposals 1, 2, and 3 are considered non-routine, so broker non-votes will not be counted for those.
• · Quorum requires a majority of outstanding shares present in person or by proxy.
• · Final voting results will be published in a Form 8-K.

04-08-2026

Carlyle Credit Income Fund (CCIF) filed a definitive proxy statement (DEF 14A) for its annual shareholder meeting to be held virtually on September 15, 2026. The sole proposal is the re-election of Independent Trustee Joan McCabe for a three-year term expiring in 2029. The filing includes standard governance details, with no financial results or operational metrics disclosed.

• · Annual meeting to be held virtually at www.virtualshareholdermeeting.com/CCIF2026 on September 15, 2026, at 10:00 a.m. Eastern Time.
• · Record date for voting is July 31, 2026.
• · Proxy materials to be mailed on or about August 4, 2026.
• · Joan McCabe has over 30 years of financial and corporate experience, including private equity and debt financing.
• · Lauren Basmadjian oversees over $48 billion of AUM within The Carlyle Group's Global Credit platform.
• · The Fund's most recent annual report includes audited financial statements for the year ended September 30, 2025.
• · Shareholders have no dissenters' or appraisal rights in connection with the proposal.
• · A majority of outstanding Preferred Shares is required for a quorum.

04-08-2026

Salarius Pharmaceuticals is seeking stockholder approval at a special meeting to allow the exercise of Milestone Warrants issued in a June 2026 private placement that raised approximately $3.5 million. If approved, the warrants could generate up to $17.5 million in additional gross proceeds, which would be used for general corporate purposes and to advance the lead asset into clinical trials. However, the company faces significant risks, including a going concern uncertainty, Nasdaq listing maintenance, and the fact that the warrants are only exercisable upon achieving specific clinical milestones that may not occur.

• · The special meeting must be held no later than 90 days after the June 29, 2026 closing date, i.e., by September 27, 2026.
• · If Stockholder Approval is not obtained at the first meeting, the company must seek approval at least every 90 days thereafter until the Milestone Warrants are no longer outstanding.
• · The Milestone Warrants expire on the earlier of 90 days after the applicable Milestone Event or June 29, 2031.
• · Series A Warrants milestone: filing of a Clinical Trial Application in the European Economic Area to commence a Phase 1 trial.
• · Series B Warrants milestone: receipt of formal written approval from the MHRA to conduct a Phase 2a human challenge trial in the UK.
• · Series C Warrants milestone: public announcement that the Phase 2a human challenge trial met its primary endpoint.
• · The Purchaser elected to receive Pre-Funded Warrants instead of Common Stock, so no shares of Common Stock were issued at closing.
• · Executive officers and directors are subject to a 90-day lock-up period following the closing date.
• · The registration statement for resale of shares underlying the warrants was filed on July 10, 2026 and declared effective on July 17, 2026.
• · The company's forward-looking statements highlight risks including going concern, Nasdaq listing maintenance, and need for additional funding.

04-08-2026

RENN Fund, Inc. filed a definitive proxy statement (DEF 14A) for its Annual Meeting of Shareholders scheduled for September 17, 2026. The meeting will include the election of five directors (Douglas J. Cohen, Russell Cleveland, Alice C. Brennan, Anita L. Allen, and Melinda J. Newman) and ratification of Tait, Weller & Baker LLP as auditor for fiscal year 2026. The filing also notes the unexpected passing of co-founder Murray Stahl in April 2026, a significant leadership loss for the Fund.

• · The record date for determining shareholders entitled to vote is July 27, 2026.
• · Proxy materials will be sent to shareholders on or about August 7, 2026.
• · The Annual Meeting will be held in hybrid format: in-person at Horizon Kinetics offices in New York and virtually via live audio webcast.
• · Shareholders must register in advance via GoToWebinar to participate virtually.
• · All five current directors are standing for re-election for one-year terms.
• · The Fund had 7,015,786 shares of common stock outstanding as of June 30, 2026.
• · A quorum requires a majority of shares entitled to vote, present in person, virtually, or by proxy.
• · Horizon Kinetics Asset Management LLC will pay all costs of solicitation.

04-08-2026

Columbus Circle Capital Corp II is holding an extraordinary general meeting on August 26, 2026, to approve a name change to Inflection Point Acquisition Corp. VII and an adjournment proposal. The name change follows the appointment of new executives affiliated with Inflection Point Asset Management LLC and is part of the company's planned business combination with Elroy Air. The company completed its IPO in February 2026, raising $230 million.

• · IPO consummated on February 12, 2026, with 23,000,000 units at $10.00 per unit.
• · Record date for the extraordinary general meeting is July 16, 2026.
• · Name change requires a special resolution with at least two-thirds majority of votes cast.
• · Adjournment proposal requires a simple majority.
• · Warrants do not have voting rights.
• · The company is a blank check company (SPAC) incorporated in the Cayman Islands.

04-08-2026

SUI Group Holdings Ltd. filed a DEF 14A proxy statement for its 2026 annual meeting scheduled for September 4, 2026. The meeting will include votes on electing six directors, reincorporating from Minnesota to Delaware, an advisory vote on executive compensation, approving stock issuance under non-employee director warrants, and an adjournment proposal. As of the July 8, 2026 record date, 76,802,872 shares of common stock were outstanding.

• · Annual meeting will be held on September 4, 2026 at 8:30 a.m. local time at 1907 Wayzata Boulevard, Suite 205, Wayzata, MN 55391, with virtual attendance option.
• · Record date for voting is July 8, 2026.
• · Quorum requires one-third of outstanding shares (approximately 25.6 million shares).
• · Proposal 2 (reincorporation to Delaware) requires an absolute majority of outstanding shares to pass.
• · All five proposals are considered non-routine under NYSE rules, so broker non-votes will count as votes AGAINST Proposals 2, 3, and 5.
• · Board recommends a vote 'FOR' all proposals.